-
Dhcr7 Knockout Grass Carp Resists GCRV
2026-09-04
A 2026 Aquaculture Reports study used CRISPR/Cas9 to identify Dhcr7, a cholesterol-biosynthesis enzyme, as an in vivo target for improving grass carp resistance to lethal GCRV-II infection. Dhcr7-disrupted fish showed higher survival, stronger Irf3-associated antiviral responses, lower viral burden, and reduced hepatopancreas injury without detectable effects on measured growth or muscle morphology.
-
Z-IETD-FMK: Caspase-8 Workflow Guide
2026-09-04
Z-IETD-FMK enables pathway-resolved studies of activated T cells, death-receptor signaling, and TRAIL responses without treating mitochondrial caspase activity as a surrogate for caspase-8 activation. This guide combines practical dosing, assay controls, solubility handling, and lessons from an ovarian cancer muscle-atrophy study.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-09-03
Song et al. show that murine norovirus uses the host membrane protein NINJ1 and caspase-3 to release the viral immune-modulatory protein NS1 through an unconventional pathway. The study links viral replication-site organization, programmed cell death, and selective protein secretion, while identifying caspase-3 as a potential determinant of oral infection in mice.
-
1-myristoylglycerophosphocholine in Cell Assays
2026-09-02
Learn how 1-myristoylglycerophosphocholine, SKU M1340, can support controlled lipid-signaling experiments involving viability, proliferation, smooth muscle responses, and fibroblast activation. This scenario-driven guide covers solvent compatibility, concentration planning, interpretation of LysoPC evidence, and practical vendor-selection criteria.
-
Capsazepine: A Translational TRPV1 Research Strategy
2026-09-02
Capsazepine is more than a pathway inhibitor: it is a mechanistic probe for separating TRPV1-dependent nociception from broader inflammatory, affective, and apoptotic biology. This thought-leadership guide connects recent cannabidiol pain research with practical Capsazepine study design, pharmacological controls, translational limitations, and emerging opportunities in pain and cancer research.
-
Rotavirus NSP4 Drives Calcium-Dependent Necroptosis
2026-09-02
The reference study identifies rotavirus NSP4 as a viral trigger that hijacks the host RIPK1–RIPK3 necrosome and activates MLKL-dependent necroptosis. Its central mechanistic advance is that NSP4-driven calcium release from the endoplasmic reticulum supports RIPK3 recruitment while bypassing the usual requirement for RIPK1 kinase activation, offering a framework for dissecting virus-induced cell death.
-
KPT-330: Turning Nuclear Export Into a Drug Strategy
2026-09-01
KPT-330 (Selinexor) offers a translational strategy for converting CRM1/XPO1 dependence into selective nuclear stress, apoptosis, and combination sensitivity. This thought-leadership analysis connects mechanistic biology with DLBCL platinum-sensitization data, NSCLC and xenograft research, assay design, and biomarker-led development.
-
SB525334: A Causal Probe of TGF-β1 Signaling
2026-08-31
SB525334 is a selective TGF-beta1 receptor inhibitor for separating reparative TGF-β1 signaling from profibrotic activity. This article translates a 2026 diabetic wound study into practical assay logic for fibrosis research, renal models, and pathway validation.
-
Dorsomorphin 2HCl: Testing AMPK Causality
2026-08-31
Dorsomorphin 2HCl is a valuable pharmacologic probe for testing whether AMPK activation drives metabolic phenotypes. Its concurrent BMP activity creates both a translational opportunity and a critical experimental-design obligation: researchers must distinguish pathway causality from compound-wide effects.
-
Patient-Derived Gastric Cancer Assembloids
2026-08-30
Shapira-Netanelov and colleagues developed a gastric cancer assembloid model that combines patient-matched tumor organoids with stromal subpopulations derived from the same tissue. The study shows that stromal composition changes gene expression and drug sensitivity, providing a more physiologically relevant platform for tumor–stroma biology, resistance studies, and personalized screening.
-
Synthetic Receptor Microglia for Amyloid-β Clearance
2026-08-29
Shao et al. developed a synthetic efferocytic receptor that redirects microglia toward amyloid-β uptake while favoring anti-inflammatory signaling. Delivered in situ with microglia-editing mRNA lipid nanoparticles, the receptor improved amyloid clearance and behavioral outcomes in mice while reducing inflammatory activity and synapse elimination.
-
CLCC1 and Herpesvirus Nuclear Egress Fusion
2026-08-28
This bioRxiv study uses a whole-genome CRISPR screen to identify CLCC1 as an essential host factor for the membrane-fusion step of herpes simplex virus 1 nuclear egress. CLCC1 loss causes perinuclear capsid accumulation, reduced viral production, and defective nuclear pore complex insertion, linking herpesvirus egress to a broader mechanism of nuclear-envelope morphogenesis.
-
Thapsigargin: Designing Causal ER Stress Assays
2026-08-28
Thapsigargin is a potent SERCA pump inhibitor for separating calcium flux, ER stress, and cell-fate responses in mechanistic assays. This guide connects its rapid pharmacology with reporter-based IRE1α studies to improve experimental design and interpretation.
-
a-MSH, Amide: A Translational Pigmentation Playbook
2026-08-28
a-MSH, amide is more than a pigmentation reagent: it is a mechanistic challenge tool for connecting melanocortin receptor biology with CREB/MITF-driven melanin synthesis and inflammation research. This thought-leadership article shows how translational teams can use it to design stronger assays, benchmark downstream inhibitors, and improve the path from cellular findings to clinically relevant pigmentation research.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Applied Workflows
2026-08-27
Pair Cy5 fluorescence with Firefly luciferase to distinguish cellular delivery from productive translation in one experiment. This guide turns that dual readout into practical mRNA delivery and transfection workflows, assay-selection decisions, and troubleshooting strategies.